{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T06:21:57Z","timestamp":1648794117850},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,12,23]],"date-time":"2009-12-23T00:00:00Z","timestamp":1261526400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1007\/s00108-009-2408-9","type":"journal-article","created":{"date-parts":[[2009,12,21]],"date-time":"2009-12-21T08:36:06Z","timestamp":1261384566000},"page":"39-44","source":"Crossref","is-referenced-by-count":2,"title":["Nephrogene systemische Fibrose"],"prefix":"10.1007","volume":"51","author":[{"given":"J.T.","family":"Kielstein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Schiffer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,12,23]]},"reference":[{"key":"2408_CR1","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1148\/radiol.2533090649","volume":"253","author":"Altun","year":"2009","unstructured":"Altun E, Martin DR, Wertman R et al. (2009) Nephrogenic systemic fibrosis: change in incidence following a switch in gadolinium agents and adoption of a gadolinium policy \u2013 report from two U.S. universities. Radiology 253: 689\u2013696","journal-title":"Radiology"},{"key":"2408_CR2","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1007\/s00467-006-0174-7","volume":"21","author":"Auron","year":"2006","unstructured":"Auron A, Shao L, Warady BA (2006) Nephrogenic fibrosing dermopathy in children. Pediatr Nephrol 21: 1307\u20131311","journal-title":"Pediatr Nephrol"},{"key":"2408_CR3","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2174\/157488807781696249","volume":"2","author":"Barth","year":"2007","unstructured":"Barth PJ, Westhoff CC (2007) CD34+ fibrocytes: morphology, histogenesis and function. Curr Stem Cell Res Ther 2: 221\u2013227","journal-title":"Curr Stem Cell Res Ther"},{"key":"2408_CR4","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s10334-007-0071-5","volume":"20","author":"Bongartz","year":"2007","unstructured":"Bongartz G (2007) Imaging in the time of NFD\/NSF: do we have to change our routines concerning renal insufficiency? MAGMA 20: 57\u201362","journal-title":"MAGMA"},{"key":"2408_CR5","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jaad.2006.10.048","volume":"56","author":"Boyd","year":"2007","unstructured":"Boyd AS, Zic JA, Abraham JL (2007) Gadolinium deposition in nephrogenic fibrosing dermopathy. J Am Acad Dermatol 56: 27\u201330","journal-title":"J Am Acad Dermatol"},{"key":"2408_CR6","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1365-4632.2005.02701.x","volume":"45","author":"Cassis","year":"2006","unstructured":"Cassis TB, Jackson JM, Sonnier GB, Callen JP (2006) Nephrogenic fibrosing dermopathy in a patient with acute renal failure never requiring dialysis. Int J Dermatol 45: 56\u201359","journal-title":"Int J Dermatol"},{"key":"2408_CR7","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1053\/j.ajkd.2008.08.029","volume":"53","author":"Chandran","year":"2009","unstructured":"Chandran S, Petersen J, Jacobs C et al. (2009) Imatinib in the treatment of nephrogenic systemic fibrosis. Am J Kidney Dis 53: 129\u2013132","journal-title":"Am J Kidney Dis"},{"key":"2408_CR8","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1001\/jama.298.17.2038","volume":"298","author":"Coresh","year":"2007","unstructured":"Coresh J, Selvin E, Stevens LA et al. (2007) Prevalence of chronic kidney disease in the United States. JAMA 298: 2038\u20132047","journal-title":"JAMA"},{"key":"2408_CR9","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1097\/00002281-200311000-00017","volume":"15","author":"Cowper","year":"2003","unstructured":"Cowper SE (2003) Nephrogenic fibrosing dermopathy: the first 6 years. Curr Opin Rheumatol 15: 785\u2013790","journal-title":"Curr Opin Rheumatol"},{"key":"2408_CR10","unstructured":"Cowper SE (2009) http:\/\/www.icnsfr.org"},{"key":"2408_CR11","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJM200504213521621","volume":"352","author":"Cowper","year":"2005","unstructured":"Cowper SE, Bucala R, Leboit PE (2005) Case 35-2004: nephrogenic fibrosing dermopathy. N Engl J Med 352: 1723\u20131724","journal-title":"N Engl J Med"},{"key":"2408_CR12","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.semarthrit.2005.09.005","volume":"35","author":"Cowper","year":"2006","unstructured":"Cowper SE, Bucala R, Leboit PE (2006) Nephrogenic fibrosing dermopathy\/nephrogenic systemic fibrosis\u2013setting the record straight. Semin Arthritis Rheum 35: 208\u2013210","journal-title":"Semin Arthritis Rheum"},{"key":"2408_CR13","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S0140-6736(00)02694-5","volume":"356","author":"Cowper","year":"2000","unstructured":"Cowper SE, Robin HS, Steinberg SM et al. (2000) Scleromyxoedema-like cutaneous diseases in renal-dialysis patients. Lancet 356: 1000\u20131001","journal-title":"Lancet"},{"key":"2408_CR14","doi-asserted-by":"crossref","first-page":"264","DOI":"10.2215\/CJN.03921106","volume":"2","author":"Deo","year":"2007","unstructured":"Deo A, Fogel M, Cowper SE (2007) Nephrogenic systemic fibrosis: a population study examining the relationship of disease development to gadolinium exposure. Clin J Am Soc Nephrol 2: 264\u2013267","journal-title":"Clin J Am Soc Nephrol"},{"key":"2408_CR15","doi-asserted-by":"crossref","first-page":"4187","DOI":"10.1016\/j.transproceed.2005.10.102","volume":"37","author":"Dundova","year":"2005","unstructured":"Dundova I, Treska V, Simanek V, Michal M (2005) Nephrogenic fibrosing dermopathy: a case study. Transplant Proc 37: 4187\u20134190","journal-title":"Transplant Proc"},{"key":"2408_CR16","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1097\/01.bor.0000245725.94887.8d","volume":"18","author":"Galan","year":"2006","unstructured":"Galan A, Cowper SE, Bucala R (2006) Nephrogenic systemic fibrosis (nephrogenic fibrosing dermopathy). Curr Opin Rheumatol 18: 614\u2013617","journal-title":"Curr Opin Rheumatol"},{"key":"2408_CR17","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1093\/ndt\/gfk062","volume":"21","author":"Grobner","year":"2006","unstructured":"Grobner T (2006) Gadolinium \u2013 a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transplant 21: 1104\u20131108","journal-title":"Nephrol Dial Transplant"},{"key":"2408_CR18","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jaad.2006.10.047","volume":"56","author":"High","year":"2007","unstructured":"High WA, Ayers RA, Chandler J (2007) Gadolinium is detectable within the tissue of patients with nephrogenic systemic fibrosis. J Am Acad Dermatol 56: 21\u201326","journal-title":"J Am Acad Dermatol"},{"key":"2408_CR19","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1002\/art.20362","volume":"50","author":"Jimenez","year":"2004","unstructured":"Jimenez SA, Artlett CM, Sandorfi N et al. (2004) Dialysis-associated systemic fibrosis (nephrogenic fibrosing dermopathy): study of inflammatory cells and transforming growth factor beta1 expression in affected skin. Arthritis Rheum 50: 2660\u20132666","journal-title":"Arthritis Rheum"},{"key":"2408_CR20","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S1076-6332(98)80191-8","volume":"5","author":"Joffe","year":"1998","unstructured":"Joffe P, Thomsen HS, Meusel M (1998) Pharmacokinetics of gadodiamide injection in patients with severe renal insufficiency and patients undergoing hemodialysis or continuous ambulatory peritoneal dialysis. Acad Radiol 5: 491\u2013502","journal-title":"Acad Radiol"},{"key":"2408_CR21","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1053\/j.ajkd.2008.09.016","volume":"53","author":"Kadiyala","year":"2009","unstructured":"Kadiyala D, Roer DA, Perazella MA (2009) Nephrogenic systemic fibrosis associated with gadoversetamide exposure: treatment with sodium thiosulfate. Am J Kidney Dis 53: 133\u2013137","journal-title":"Am J Kidney Dis"},{"key":"2408_CR22","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1136\/pgmj.2008.069831","volume":"85","author":"Klass","year":"2009","unstructured":"Klass BR, Grobbelaar AO, Rolfe KJ (2009) Transforming growth factor beta1 signalling, wound healing and repair: a multifunctional cytokine with clinical implications for wound repair, a delicate balance. Postgrad Med J 85: 9\u201314","journal-title":"Postgrad Med J"},{"key":"2408_CR23","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1148\/radiol.2423061640","volume":"242","author":"Kuo","year":"2007","unstructured":"Kuo PH, Kanal E, Abu-Alfa AK, Cowper SE (2007) Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis. Radiology 242: 647\u2013649","journal-title":"Radiology"},{"key":"2408_CR24","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1001\/archderm.139.7.928","volume":"139","author":"Leboit","year":"2003","unstructured":"Leboit PE (2003) What nephrogenic fibrosing dermopathy might be. Arch Dermatol 139: 928\u2013930","journal-title":"Arch Dermatol"},{"key":"2408_CR25","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.2174\/138161205774913336","volume":"11","author":"Lorusso","year":"2005","unstructured":"Lorusso V, Pascolo L, Fernetti C et al. (2005) Magnetic resonance contrast agents: from the bench to the patient. Curr Pharm Des 11: 4079\u20134098","journal-title":"Curr Pharm Des"},{"key":"2408_CR26","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.semarthrit.2005.08.002","volume":"35","author":"Mendoza","year":"2006","unstructured":"Mendoza FA, Artlett CM, Sandorfi N (2006) Description of 12 cases of nephrogenic fibrosing dermopathy and review of the literature. Semin Arthritis Rheum 35: 238\u2013249","journal-title":"Semin Arthritis Rheum"},{"key":"2408_CR27","doi-asserted-by":"crossref","first-page":"461","DOI":"10.2215\/CJN.06011108","volume":"4","author":"Perazella","year":"2009","unstructured":"Perazella MA (2009) Current status of gadolinium toxicity in patients with kidney disease. Clin J Am Soc Nephrol 4: 461\u2013469","journal-title":"Clin J Am Soc Nephrol"},{"key":"2408_CR28","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s11604-006-0055-9","volume":"24","author":"Saitoh","year":"2006","unstructured":"Saitoh T, Hayasaka K, Tanaka Y et al. (2006) Dialyzability of gadodiamide in hemodialysis patients. Radiat Med 24: 445\u2013451","journal-title":"Radiat Med"},{"key":"2408_CR29","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1093\/ndt\/gfh473","volume":"20","author":"Schmook","year":"2005","unstructured":"Schmook T, Budde K, Ulrich C et al. (2005) Successful treatment of nephrogenic fibrosing dermopathy in a kidney transplant recipient with photodynamic therapy. Nephrol Dial Transplant 20: 220\u2013222","journal-title":"Nephrol Dial Transplant"},{"key":"2408_CR30","doi-asserted-by":"crossref","first-page":"968","DOI":"10.2215\/CJN.00100108","volume":"3","author":"Schroeder","year":"2008","unstructured":"Schroeder JA, Weingart C, Coras B et al. (2008) Ultrastructural evidence of dermal gadolinium deposits in a patient with nephrogenic systemic fibrosis and end-stage renal disease. Clin J Am Soc Nephrol 3: 968\u2013975","journal-title":"Clin J Am Soc Nephrol"},{"key":"2408_CR31","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1097\/00004424-199111000-00009","volume":"26","author":"Schuhmann-Giampieri","year":"1991","unstructured":"Schuhmann-Giampieri G, Krestin G (1991) Pharmacokinetics of Gd-DTPA in patients with chronic renal failure. Invest Radiol 26: 975\u2013979","journal-title":"Invest Radiol"},{"key":"2408_CR32","doi-asserted-by":"crossref","first-page":"736","DOI":"10.2214\/AJR.07.3115","volume":"190","author":"Shabana","year":"2008","unstructured":"Shabana WM, Cohan RH, Ellis JH et al. (2008) Nephrogenic systemic fibrosis: a report of 29 cases. AJR Am J Roentgenol 190: 736\u2013741","journal-title":"AJR Am J Roentgenol"},{"key":"2408_CR33","doi-asserted-by":"crossref","first-page":"234","DOI":"10.7326\/0003-4819-145-3-200608010-00021","volume":"145","author":"Swaminathan","year":"2006","unstructured":"Swaminathan S, Ahmed I, McCarthy JT et al. (2006) Nephrogenic fibrosing dermopathy and high-dose erythropoietin therapy. Ann Intern Med 145: 234\u2013235","journal-title":"Ann Intern Med"},{"key":"2408_CR34","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1681\/ASN.2007060645","volume":"18","author":"Swaminathan","year":"2007","unstructured":"Swaminathan S, Shah SV (2007) New insights into nephrogenic systemic fibrosis. J Am Soc Nephrol 18: 2636\u20132643","journal-title":"J Am Soc Nephrol"},{"key":"2408_CR35","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/00004424-199907000-00001","volume":"34","author":"Swan","year":"1999","unstructured":"Swan SK, Lambrecht LJ, Townsend R et al. (1999) Safety and pharmacokinetic profile of gadobenate dimeglumine in subjects with renal impairment. Invest Radiol 34: 443\u2013448","journal-title":"Invest Radiol"},{"key":"2408_CR36","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0002-9343(03)00085-8","volume":"114","author":"Swartz","year":"2003","unstructured":"Swartz RD, Crofford LJ, Phan SH et al. (2003) Nephrogenic fibrosing dermopathy: a novel cutaneous fibrosing disorder in patients with renal failure. Am J Med 114: 563\u2013572","journal-title":"Am J Med"},{"key":"2408_CR37","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1001\/archdermatol.2009.245","volume":"145","author":"Tran","year":"2009","unstructured":"Tran KT, Prather HB, Cockerell CJ, Jacobe H (2009) UV-A1 therapy for nephrogenic systemic fibrosis. Arch Dermatol 145: 1170\u20131174","journal-title":"Arch Dermatol"},{"key":"2408_CR38","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/RLI.0b013e31818f76b5","volume":"44","author":"Varani","year":"2009","unstructured":"Varani J, DaSilva M, Warner RL et al. (2009) Effects of gadolinium-based magnetic resonance imaging contrast agents on human skin in organ culture and human skin fibroblasts. Invest Radiol 44: 74\u201381","journal-title":"Invest Radiol"},{"key":"2408_CR39","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1681\/ASN.2006030301","volume":"17","author":"Weisbord","year":"2006","unstructured":"Weisbord SD, Chen H, Stone RA et al. (2006) Associations of increases in serum creatinine with mortality and length of hospital stay after coronary angiography. J Am Soc Nephrol 17: 2871\u20132877","journal-title":"J Am Soc Nephrol"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-009-2408-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-009-2408-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-009-2408-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T04:12:13Z","timestamp":1558584733000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-009-2408-9"}},"subtitle":["Eine seltene Erkrankung mit schwerwiegenden Folgen"],"short-title":[],"issued":{"date-parts":[[2009,12,23]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["2408"],"URL":"https:\/\/doi.org\/10.1007\/s00108-009-2408-9","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12,23]]}}}